GL1X · GenesisL1 explorer

MolNFT v1 · #134393 · protein

Crystal structure of lymphocytic choriomeningitis mammarenavirus endonuclease bound to compound L742001

5T2T · RNA-directed RNA polymerase L: “Crystal structure of lymphocytic choriomeningitis mammarenavirus endonuclease bound to compound L742001”. X-ray diffraction, 4 ligands (0N8, MN, NA), 3 pockets (best druggability 0.46). MolNFT v1…

PDB
5T2T
Type
protein
Length
388 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase L
EC
2.7.7.48
UniProt
A0A059U382
Ligands
0N8, MN, NA, CL
Pockets
3 · best druggability 0.46

Structure

x-ray diffraction · 2 distinct chains · 55% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase L (EC 2.7.7.48)protein18954% helix, 13% strandA0A059U382
BRNA-directed RNA polymerase L (EC 2.7.7.48)protein19956% helix, 13% strandA0A059U382

Ligands and binding sites

  • 0N8 · (2Z)-4-[1-benzyl-4-(4-chlorobenzyl)piperidin-4-yl]-2-hydroxy-4-oxobut-2-enoic acid · ligand · chains A
  • MN · Manganese (II) ion · metal · 2 copies · chains A
  • NA · Sodium ion · metal · 2 copies · chains B
  • CL · Chloride ion · ion · 2 copies · chains B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11520.460.7719GOL
2710.310.7414empty
3590.280.7419MN

Interfaces

1 interface between chains.

  • A–B · 650 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 5T2T · Crystal structure of Lymphocytic choriomeningitis mammarenavirus endonuclease bound to… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.